Literature DB >> 29610116

Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN.

Chi Yan Ooi1, Daniel R Carter1,2, Bing Liu1, Chelsea Mayoh1, Anneleen Beckers3, Amit Lalwani1, Zsuzsanna Nagy1, Sara De Brouwer3, Bieke Decaesteker3, Tzong-Tyng Hung4, Murray D Norris1,5, Michelle Haber1, Tao Liu1, Katleen De Preter3, Frank Speleman3, Belamy B Cheung6,2, Glenn M Marshall6,2,7.   

Abstract

Neuroblastoma is a pediatric cancer of the sympathetic nervous system where MYCN amplification is a key indicator of poor prognosis. However, mechanisms by which MYCN promotes neuroblastoma tumorigenesis are not fully understood. In this study, we analyzed global miRNA and mRNA expression profiles of tissues at different stages of tumorigenesis from TH-MYCN transgenic mice, a model of MYCN-driven neuroblastoma. On the basis of a Bayesian learning network model in which we compared pretumor ganglia from TH-MYCN+/+ mice to age-matched wild-type controls, we devised a predicted miRNA-mRNA interaction network. Among the miRNA-mRNA interactions operating during human neuroblastoma tumorigenesis, we identified miR-204 as a tumor suppressor miRNA that inhibited a subnetwork of oncogenes strongly associated with MYCN-amplified neuroblastoma and poor patient outcome. MYCN bound to the miR-204 promoter and repressed miR-204 transcription. Conversely, miR-204 directly bound MYCN mRNA and repressed MYCN expression. miR-204 overexpression significantly inhibited neuroblastoma cell proliferation in vitro and tumorigenesis in vivo Together, these findings identify novel tumorigenic miRNA gene networks and miR-204 as a tumor suppressor that regulates MYCN expression in neuroblastoma tumorigenesis.Significance: Network modeling of miRNA-mRNA regulatory interactions in a mouse model of neuroblastoma identifies miR-204 as a tumor suppressor and negative regulator of MYCN. Cancer Res; 78(12); 3122-34. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29610116     DOI: 10.1158/0008-5472.CAN-17-3034

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma.

Authors:  Holly Holliday; Jessica Yang; Eoin Dodson; Iva Nikolic; Alvin Kamili; Madeleine Wheatley; Niantao Deng; Sarah Alexandrou; Thomas P Davis; Maria Kavallaris; C Elizabeth Caldon; Joshua McCarroll; Katleen De Preter; Pieter Mestdagh; Glenn M Marshall; Kaylene J Simpson; Jamie Fletcher; Alexander Swarbrick
Journal:  Mol Ther       Date:  2022-01-05       Impact factor: 11.454

2.  TTF1 suppresses neuroblastoma growth and induces neuroblastoma differentiation by targeting TrkA and the miR-204/TrkB axis.

Authors:  Tianyou Yang; Jiahao Li; Zhenjian Zhuo; Huijuan Zeng; Tianbao Tan; Lei Miao; Manna Zheng; Jiliang Yang; Jing Pan; Chao Hu; Yan Zou; Jing He; Huimin Xia
Journal:  iScience       Date:  2022-06-23

3.  miR-20a regulates sensitivity of colorectal cancer cells to NK cells by targeting MICA.

Authors:  Siwen Tang; Hongyu Fu; Qihua Xu; Ying Zhou
Journal:  Biosci Rep       Date:  2019-07-02       Impact factor: 3.840

4.  CUL4B contributes to cancer stemness by repressing tumor suppressor miR34a in colorectal cancer.

Authors:  Yanjun Li; Huili Hu; Yuxing Wang; Yujia Fan; Yang Yang; Beibei Guo; Xueyong Xie; Jiabei Lian; Baichun Jiang; Bo Han; Yanlei Wang; Changshun Shao; Yaoqin Gong
Journal:  Oncogenesis       Date:  2020-02-13       Impact factor: 7.485

5.  Astragalus polysaccharide attenuates metabolic memory-triggered ER stress and apoptosis via regulation of miR-204/SIRT1 axis in retinal pigment epithelial cells.

Authors:  Qing-Hua Peng; Ping Tong; Li-Min Gu; Wen-Jie Li
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

6.  MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma.

Authors:  Zehang Zhuang; Pei Yu; Nan Xie; Yue Wu; Haichao Liu; Ming Zhang; Yifan Tao; Weiwang Wang; Hanqi Yin; Bin Zou; Jinsong Hou; Xiqiang Liu; Jiong Li; Hongzhang Huang; Cheng Wang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

7.  Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells.

Authors:  Lufeng Zheng; Qianqian Guo; Chenxi Xiang; Shijia Liu; Yuzhang Jiang; Lanlan Gao; Haiwei Ni; Ting Wang; Qiong Zhao; Hai Liu; Yingying Xing; Yaohui Wang; Xiaoman Li; Tao Xi
Journal:  J Hematol Oncol       Date:  2019-03-04       Impact factor: 17.388

8.  MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion.

Authors:  Ken Yasukawa; Lee Chuen Liew; Keitaro Hagiwara; Ai Hironaka-Mitsuhashi; Xian-Yang Qin; Yutaka Furutani; Yasuhito Tanaka; Hitoshi Nakagama; Soichi Kojima; Takashi Kato; Takahiro Ochiya; Luc Gailhouste
Journal:  Cancer Sci       Date:  2020-01-25       Impact factor: 6.716

9.  MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution.

Authors:  Natarajan Aravindan; Karthikeyan Subramanian; Dinesh Babu Somasundaram; Terence S Herman; Sheeja Aravindan
Journal:  Cancer Drug Resist       Date:  2019-12-19

10.  miR-149 inhibits cell proliferation and enhances chemosensitivity by targeting CDC42 and BCL2 in neuroblastoma.

Authors:  Fengxia Mao; Ju Zhang; Xinru Cheng; Qianya Xu
Journal:  Cancer Cell Int       Date:  2019-12-27       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.